| ²é¿´: 628 | »Ø¸´: 0 | |||
yexuqingľ³æÖ®Íõ (ÎÄѧ̩¶·)
Ì«ÑôϵϵÖ÷ÈÎ
|
[½»Á÷]
±±¾©Í¬ÈÊÒ½ÔºÒ»ÂÛÎı»³·£ºÉæÖظ´·¢±í¡¢Î±Ôì×÷ÕßÉí·Ý¡¢±àÔìÊý¾Ý
|
|
ÒòÉæÏÓÖØ¸´·¢±í¡¢ αÔì×÷ÕßÉí·Ý¡¢±àÔìÊý¾ÝµÈÔÒò£¬Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿ÆÖ÷ÈΡ¢±±¾©ÊÐÌÇÄò²¡Ñо¿ËùËù³¤Ñî½ð¿üºÍÊ×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿ÆÖ÷ÈÎҽʦÖܽ¨²©ÊðÃûΪͨѶ×÷ÕßµÄһƪÑо¿ÂÛÎı»³·»Ø¡£ 3ÔÂ10ÈÕ£¬¹ú¼ÊѧÊõÆÚ¿¯¡¶Ò½Ñ§¡·£¨Medicine£©·¢±íÒ»·Ý³·¸å˵Ã÷³Æ£¬¸ÃÆÚ¿¯µÚ96¾íµÚ15ÆÚÉÏ·¢±íµÄһƪÂÛÎÄ£¬ÒòÉæÏÓÖØ¸´·¢±í¡¢ αÔì×÷ÕßÉí·Ý¡¢±àÔìÊý¾ÝºÍαÔìÐèҪͨѶ×÷ÕßÐí¿ÉµÄ³ö°æÐÒé¶ø±»³·»Ø¡£ ÉæÊÂÂÛÎĵıêÌâÊÇ¡¶ÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍ˺ÍT2DÊÜÊÔÕßÂýÐÔÉöÔ༲²¡µÄ·çÏÕ£º²¡Àý¶ÔÕպͼÁÁ¿·´Ó¦·ÖÎö¡·£¨Subclinical hypothyroidism and the risk of chronic kidney disease in T2D subjects: A case-control and dose-response analysis£©¡£ ¸ÃÂÛÎÄÓÚ2017Äê4Ô·¢±íÔÚѧÊõÆÚ¿¯¡¶Ò½Ñ§¡·£¨Medicine£©ÉÏ¡£ÆäͨѶ×÷Õß·Ö±ðÊÇÖܽ¨²©(Jian-Bo Zhou)ºÍÑî½ð¿ü(Jin-Kui Yang)¡£ ÆäÖУ¬Öܽ¨²©(Jian-Bo Zhou)µÄÊðÃûµ¥Î»ÊÇÊ×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿Æ¡£Ñî½ð¿ü(Jin-Kui Yang)µÄÊðÃûµ¥Î»ÊÇÊ×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃڿƺÍÌÇÄò²¡Ñо¿·ÀÖα±¾©ÊÐÖØµãʵÑéÊÒ¡£ 2023Äê3ÔÂ10Èյij·¸å˵Ã÷¡£ ÉæÊÂÂÛÎijƣ¬ËäÈ»´ËǰÓÐÖ¤¾Ý±íÃ÷ÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍËÖ¢(SCH)ÓëÐÄѪ¹Ü¼²²¡³ÊÕýÏà¹Ø£¬µ«ÓëÂýÐÔÉöÔ༲²¡(CKD)Ö®¼äµÄ¹ØÏµÉв»Çå³þ¡£¸ÃÑо¿ÕÐļÁË3270Àý2ÐÍÌÇÄò²¡ºÏ²¢¼×¿º»¼ÕߺÍ545Àý2ÐÍÌÇÄò²¡ºÏ²¢¼×¿º»¼Õߣ¬²¢½øÐÐÜöÝÍ·ÖÎö¡£Ñо¿·¢ÏÖ£¬ÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍËÖ¢(SCH)¿ÉÄÜÊÇ2ÐÍÌÇÄò²¡ÊÜÊÔÕßÖÐÂýÐÔÉöÔ༲²¡µÄÒ»¸öÖØÒª·çÏÕÒòËØ¡£ÔÚ2ÐÍÌÇÄò²¡ÊÜÊÔÕßÖУ¬ÑªÇå´Ù¼××´ÏÙ¼¤ËØ(TSH)µÄÉý¸ßºÍÂýÐÔÉöÔ༲²¡Ö®¼äÏÔʾ³öÏßÐÔÇ÷ÊÆ¡£ µ«ÔÚ·¢±í½ü6Äêºó£¬ÉÏÊöÂÛÎı»³·»Ø¡£ ¹«¿ª×ÊÁÏÏÔʾ£¬ÉæÊÂÂÛÎĵÄͨѶ×÷ÕßÖܽ¨²©ÓëÑî½ð¿üÔÚ±±¾©Í¬ÈÊÒ½Ôº±»ÁÐΪͬһ¼¼ÊõÍŶӡ£ Öܽ¨²©£¬ÏµÒ½Ñ§²©Ê¿£¬Ö÷ÈÎҽʦ£¬¸±½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦£¬±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃڿƸ±Ö÷ÈÎÖ÷³Ö¹¤×÷£»2010Äê±ÏÒµÓÚÊ×¶¼Ò½¿Æ´óѧ£¬Í¬Äê8ÔÂÖÁ¸ÃÔºÄÚ·ÖÃڿƹ¤×÷ÖÁ½ñ¡£¶àÄê´ÓÊÂÄÚ·ÖÃÚ´úл²¡»ù´¡¼°ÁÙ´²¹¤×÷£¬ÖÂÁ¦ÓÚÀÏÄêÌÇÄò²¡¡¢¼××´ÏÙÏà¹ØÑÛ²¡¡¢ÄÑÖÎÐÔ¸ßѪѹµÈ¼²²¡ÕïÖΣ»ÆäÎÄÕ·¢±íÔÚMetabolism, Ageing Research Reviews, Neurosci Biobehav Rev, Diabetes Care£»µ£ÈÎJournal of Alzheimer¡¯s Disease¸±Ö÷±à¡¢Frontiers in Neuroscience¡¢Frontiers in EndocrinologyÌØÑû¸±Ö÷±à¡£ Ñî½ð¿ü£¬ÏµÖ÷ÈÎҽʦ£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦£»ÏÖÈα±¾©ÊÐÌÇÄò²¡Ñо¿ËùËù³¤£¬Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿ÆÖ÷ÈΣ¬Ê×¶¼Ò½¿Æ´óѧÄÚ·ÖÃÚÓë´úл²¡Ñ§ÏµÖ÷ÈΣ»×÷ΪÊ×ϯ¿ÆÑ§¼Ò³Ðµ£¹ú¼ÒÖØµãÑз¢ÏîÄ¿1ÏÖ÷³Ö¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØµã¡¢¹ú¼ÊºÏ×÷¼°ÃæÉÏÏîÄ¿¹²7Ïî¡£·¢±íÂÛÎÄ269ƪ£¬±»Òý2505´Î¡£´ú±íÐÔÂÛÎÄ·¢±íÔÚ¡¶Diabetes Care¡· (IF£º15.3)¹²4ƪ£¬¡¶Cell Reports¡·1ƪ£¬¡¶Nature Communications¡·1ƪ£¬¡¶Diabetes¡·2ƪ¡£ÆäÖнü10ÄêÒÔµÚÒ»/ͨѶ×÷Õß·¢±íSCIÂÛÖø54ƪ£»×÷ΪµÚÒ»Íê³ÉÈË»ñÊ¡¼¶¿Æ¼¼½±6Ï¹ú¼ÒÐÂÒ©Ö¤Êé2Ïî¡£ ÖµµÃ×¢ÒâµÄÊÇ£¬ÁíÓÐһƪÆäËû×÷ÕßÊðÃûµÄÂÛÎÄËäÈ»±»ÁÐÔÚ³·¸åÉùÃ÷ÖÐ×÷Ϊ±»³·¸åÂÛÎÄÉæÏÓ¡°Öظ´·¢±í¡±µÄÂÛÎÄ£¬µ«ÆäÁÐÃ÷µÄ¾íºÅºÍÒ³Âë¼°±êÌâ¾ùδÄܼìË÷µ½¡£¸ÃÂÛÎĵıêÌâÊÇ¡¶T2DM»¼ÕßÂýÐÔÉöÔ༲²¡ÓëÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍ˵ĹØÏµ£º²¡Àý¶ÔÕպͼÁÁ¿·´Ó¦·ÖÎö¡·£¨Relationship between chronic kidney disease and subclinical hypothyroidism in T2DM subjects: a case-control and dose-response analysis£©¡£ 13ÈÕ£¬Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½Ôº¿Æ¼¼´¦¹¤×÷ÈËÔ±ÏòÅìÅȿƼ¼±íʾ£¬¶ÔÉÏÊö³·¸åÇé¿ö²»ÖªÇé¡£ ÔðÈα༣ºÎâԾΰ ͼƬ±à¼£º½¯Á¢¶¬ |
» ²ÂÄãϲ»¶
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺÉúÖ³½¡¿µÑо¿ËùÕÐÆ¸¼¼ÊõÈËÔ±£¨Ë¶Ê¿£©£¨Óбࣩ
ÒѾÓÐ25È˻ظ´
µÚ¶þ´ÎÉêÇëÃæÉÏδÖУ¬Çë´óÀÐÃǰïæ¿´¿´£¬ÖµµÃÐÞ¸Äô£¿»¹ÊÇ»»Íêȫеı¾×Ó¡£
ÒѾÓÐ60È˻ظ´
ÒÅ´«Ñ§ÓëÉúÎïÐÅϢѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ290È˻ظ´
sybyl¶Ô½Ó½á¹û²»ÏÔʾCScore½á¹ûÊÇÎªÊ²Ã´ÄØ£¿
ÒѾÓÐ1È˻ظ´
NC±»¾ÜºóÉêËß
ÒѾÓÐ8È˻ظ´
¹ØÓÚ ½üÎåÄêÖ÷³Ö»ò²Î¼ÓµÄÆäËû¿ÆÑÐÏîÄ¿/¿ÎÌ⣨¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿³ýÍ⣩µÄÒÉÎÊ
ÒѾÓÐ48È˻ظ´
ÎÄÏ×¼ÆÁ¿Ñ§3ÇøÌ«ÄÑÁË£¬Çó´óÉñÖ¸µ¼
ÒѾÓÐ5È˻ظ´














»Ø¸´´ËÂ¥
30